Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable Device (eMSGait)

Nantes University Hospital (NUH)

Status: Completed

Conditions: Multiple Sclerosis

Treatments: Other: Wearable sensor

Study type: Observational

Funder types: Other

Identifiers

NCT04969848

RC21_0070

Details and patient eligibility

About

Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. The development of wearable device offers the opportunity to collect data during daily activity including walking.

Full description

Umanit and LMJ (Nantes university) has developed a device call eMSgait to assess walking ability in MS patients individuals (eg MS patients). This device consists in a commercialized IMU sensor (MetaMotionR Sensor, Mbientilab) worn at the right hip, a smartphone app and dedicated algorithm/mathematical model to extract raw sensor data and calculate individual gait pattern (IGP). This IGP consists of a curve, based on quaternion and representing the rotation recorded by the IMU during an average gait cycle. Pursue first pilot work assessing information from IGP on gait alteration in MS.

Enrollment: 44 patients

Sex: All

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 - 64 years
• Diagnosis of MS based on McDonald criteria (including Relapsing-remitting and progressive MS)
• No relapse within the last 5 weeks before recruitment
• Able to walk with or without assistance/help/aid (one or 2 canes)
• EDSS [0-6]

Exclusion criteria

• Women who are pregnant
• Patient having expressed their opposition
• Patient under guardianship or security measure

Trial design

44 participants in 1 patient group

eMSGait

Description:

Record of IGP using IMU sensor (Metamotion R mbientlab) during T25FW.

Treatment:

Other: Wearable sensor